학술논문

A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)
Document Type
Article
Source
In Clinical Breast Cancer February 2022 22(2):103-114
Subject
Language
ISSN
1526-8209